Harrow, Inc. Stock Issued During Period, Shares, Restricted Stock Award, Forfeited
Harrow, Inc. (HROW) reported Stock Issued During Period, Shares, Restricted Stock Award, Forfeited of 6.87 thousand shares for the 2-month period ending 2013-10-31, per its 10-K filed 2014-03-28.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited · last filed 2014-03-28
- 2013-10-31: Stock Issued During Period, Shares, Restricted Stock Award, Forfeited 2 month 6.87K shares.
| Period end | Stock Issued During Period, Shares, Restricted Stock Award, Forfeited 2 month |
|---|---|
| 2013-10-31 | 6.87K shares 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |